Source: Medical Device Network

Ultromics: Ultromics's EchoGo misses primary endpoint in heart disease trial

Whilst the trial's endpoint did not show statistical significance, the AI-augmentation tool showed promise for less-experienced clinicians. The post Ultromics's EchoGo misses primary endpoint in heart disease trial appeared first on Medical Device Network.

Read full article »

Ultromics's Competitors | Ultromics's News | Ultromics's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Ross Upton

CEO Approval Rating

65/100

Ultrasonics is an England-based AI-enabled medical imaging company that offers echo analysis and ultrasound imaging solutions to detect and treat cardiovascular diseases.